DAFNA Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-13,984
| Closed | -$1.89M | – | 79 |
|
|
2017
Q4 | $1.89M | Hold |
13,984
| – | – | 1.02% | 32 |
|
|
2017
Q3 | $1.72M | Hold |
13,984
| – | – | 1.07% | 28 |
|
|
2017
Q2 | $1.35M | Sell |
13,984
-32
| -0.2% | -$3.08K | 0.96% | 34 |
|
|
2017
Q1 | $2.61M | Hold |
14,016
| – | – | 2.21% | 13 |
|
|
2016
Q4 | $1.52M | Hold |
14,016
| – | – | 1.34% | 31 |
|
|
2016
Q3 | $2.25M | Hold |
14,016
| – | – | 1.56% | 22 |
|
|
2016
Q2 | $1.7M | Buy |
+14,016
| New | +$1.7M | 1.35% | 21 |
|